295 related articles for article (PubMed ID: 31120998)
1. HoxA9 binds and represses the Cebpa +8 kb enhancer.
Peng L; Guo H; Ma P; Sun Y; Dennison L; Aplan PD; Hess JL; Friedman AD
PLoS One; 2019; 14(5):e0217604. PubMed ID: 31120998
[TBL] [Abstract][Full Text] [Related]
2. In Vivo Deletion of the Cebpa +37 kb Enhancer Markedly Reduces Cebpa mRNA in Myeloid Progenitors but Not in Non-Hematopoietic Tissues to Impair Granulopoiesis.
Guo H; Cooper S; Friedman AD
PLoS One; 2016; 11(3):e0150809. PubMed ID: 26937964
[TBL] [Abstract][Full Text] [Related]
3. The +37 kb Cebpa Enhancer Is Critical for Cebpa Myeloid Gene Expression and Contains Functional Sites that Bind SCL, GATA2, C/EBPα, PU.1, and Additional Ets Factors.
Cooper S; Guo H; Friedman AD
PLoS One; 2015; 10(5):e0126385. PubMed ID: 25938608
[TBL] [Abstract][Full Text] [Related]
4. Runx1 deletion or dominant inhibition reduces Cebpa transcription via conserved promoter and distal enhancer sites to favor monopoiesis over granulopoiesis.
Guo H; Ma O; Speck NA; Friedman AD
Blood; 2012 May; 119(19):4408-18. PubMed ID: 22451420
[TBL] [Abstract][Full Text] [Related]
5. The Cebpa +37-kb enhancer directs transgene expression to myeloid progenitors and to long-term hematopoietic stem cells.
Guo H; Ma O; Friedman AD
J Leukoc Biol; 2014 Sep; 96(3):419-26. PubMed ID: 24868087
[TBL] [Abstract][Full Text] [Related]
6. C/EBPα induces Ebf1 gene expression in common lymphoid progenitors.
Barberi T; Cui C; Friedman AD
PLoS One; 2020; 15(12):e0244161. PubMed ID: 33332417
[TBL] [Abstract][Full Text] [Related]
7. Progression from the Common Lymphoid Progenitor to B/Myeloid PreproB and ProB Precursors during B Lymphopoiesis Requires C/EBPα.
Guo H; Barberi T; Suresh R; Friedman AD
J Immunol; 2018 Sep; 201(6):1692-1704. PubMed ID: 30061199
[TBL] [Abstract][Full Text] [Related]
8. An autonomous CEBPA enhancer specific for myeloid-lineage priming and neutrophilic differentiation.
Avellino R; Havermans M; Erpelinck C; Sanders MA; Hoogenboezem R; van de Werken HJ; Rombouts E; van Lom K; van Strien PM; Gebhard C; Rehli M; Pimanda J; Beck D; Erkeland S; Kuiken T; de Looper H; Gröschel S; Touw I; Bindels E; Delwel R
Blood; 2016 Jun; 127(24):2991-3003. PubMed ID: 26966090
[TBL] [Abstract][Full Text] [Related]
9. Enhancer and Transcription Factor Dynamics during Myeloid Differentiation Reveal an Early Differentiation Block in Cebpa null Progenitors.
Pundhir S; Bratt Lauridsen FK; Schuster MB; Jakobsen JS; Ge Y; Schoof EM; Rapin N; Waage J; Hasemann MS; Porse BT
Cell Rep; 2018 May; 23(9):2744-2757. PubMed ID: 29847803
[TBL] [Abstract][Full Text] [Related]
10. Nup98-HoxA9 immortalizes myeloid progenitors, enforces expression of Hoxa9, Hoxa7 and Meis1, and alters cytokine-specific responses in a manner similar to that induced by retroviral co-expression of Hoxa9 and Meis1.
Calvo KR; Sykes DB; Pasillas MP; Kamps MP
Oncogene; 2002 Jun; 21(27):4247-56. PubMed ID: 12082612
[TBL] [Abstract][Full Text] [Related]
11. NUP98-HOXA9-transgenic zebrafish develop a myeloproliferative neoplasm and provide new insight into mechanisms of myeloid leukaemogenesis.
Forrester AM; Grabher C; McBride ER; Boyd ER; Vigerstad MH; Edgar A; Kai FB; Da'as SI; Payne E; Look AT; Berman JN
Br J Haematol; 2011 Oct; 155(2):167-81. PubMed ID: 21810091
[TBL] [Abstract][Full Text] [Related]
12. NUP98-HOXA9 bearing therapy-related myeloid neoplasm involves myeloid-committed cell and induces HOXA5, EVI1, FLT3, and MEIS1 expression.
Burillo-Sanz S; Morales-Camacho RM; Caballero-Velázquez T; Vargas MT; García-Lozano JR; Falantes JF; Prats-Martín C; Bernal R; Pérez-Simón JA
Int J Lab Hematol; 2016 Feb; 38(1):64-71. PubMed ID: 26418229
[TBL] [Abstract][Full Text] [Related]
13. Granulopoiesis requires increased C/EBPα compared to monopoiesis, correlated with elevated Cebpa in immature G-CSF receptor versus M-CSF receptor expressing cells.
Ma O; Hong S; Guo H; Ghiaur G; Friedman AD
PLoS One; 2014; 9(4):e95784. PubMed ID: 24752325
[TBL] [Abstract][Full Text] [Related]
14. EVI1 Interferes with Myeloid Maturation via Transcriptional Repression of Cebpa, via Binding to Two Far Downstream Regulatory Elements.
Wilson M; Tsakraklides V; Tran M; Xiao YY; Zhang Y; Perkins AS
J Biol Chem; 2016 Jun; 291(26):13591-607. PubMed ID: 27129260
[TBL] [Abstract][Full Text] [Related]
15. The regulatory control of Cebpa enhancers and silencers in the myeloid and red-blood cell lineages.
Repele A; Krueger S; Bhattacharyya T; Tuineau MY; Manu
PLoS One; 2019; 14(6):e0217580. PubMed ID: 31181110
[TBL] [Abstract][Full Text] [Related]
16. HOXA9 activates transcription of the gene encoding gp91Phox during myeloid differentiation.
Bei L; Lu Y; Eklund EA
J Biol Chem; 2005 Apr; 280(13):12359-70. PubMed ID: 15681849
[TBL] [Abstract][Full Text] [Related]
17. The oncogene Nup98-HOXA9 induces gene transcription in myeloid cells.
Ghannam G; Takeda A; Camarata T; Moore MA; Viale A; Yaseen NR
J Biol Chem; 2004 Jan; 279(2):866-75. PubMed ID: 14561764
[TBL] [Abstract][Full Text] [Related]
18. C/EBPα-p30 confers AML cell susceptibility to the terminal unfolded protein response and resistance to Venetoclax by activating DDIT3 transcription.
Du M; Wang M; Liu M; Fu S; Lin Y; Huo Y; Yu J; Yu X; Wang C; Xiao H; Wang L
J Exp Clin Cancer Res; 2024 Mar; 43(1):79. PubMed ID: 38475919
[TBL] [Abstract][Full Text] [Related]
19. Leukemogenic mechanisms and targets of a NUP98/HHEX fusion in acute myeloid leukemia.
Jankovic D; Gorello P; Liu T; Ehret S; La Starza R; Desjobert C; Baty F; Brutsche M; Jayaraman PS; Santoro A; Mecucci C; Schwaller J
Blood; 2008 Jun; 111(12):5672-82. PubMed ID: 18388181
[TBL] [Abstract][Full Text] [Related]
20. HoxA9 regulated Bcl-2 expression mediates survival of myeloid progenitors and the severity of HoxA9-dependent leukemia.
Brumatti G; Salmanidis M; Kok CH; Bilardi RA; Sandow JJ; Silke N; Mason K; Visser J; Jabbour AM; Glaser SP; Okamoto T; Bouillet P; D'Andrea RJ; Ekert PG
Oncotarget; 2013 Nov; 4(11):1933-47. PubMed ID: 24177192
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
